HALO foredrag Endoskopi Sygeplejerskernes Årsmøde 2013.

Slides:



Advertisements
Similar presentations
TWO STEP EQUATIONS 1. SOLVE FOR X 2. DO THE ADDITION STEP FIRST
Advertisements

You have been given a mission and a code. Use the code to complete the mission and you will save the world from obliteration…
Evaluation of Oral Azacitidine Using Extended Treatment Schedules: A Phase I Study Garcia-Manero G et al. Proc ASH 2010;Abstract 603.
Kapitel 21 Astronomie Autor: Bennett et al. Galaxienentwicklung Kapitel 21 Galaxienentwicklung © Pearson Studium 2010 Folie: 1.
Slide 1 Insert your own content. Slide 2 Insert your own content.
Copyright © 2011, Elsevier Inc. All rights reserved. Chapter 5 Author: Julia Richards and R. Scott Hawley.
1 Copyright © 2010, Elsevier Inc. All rights Reserved Fig 2.1 Chapter 2.
1 Chapter 40 - Physiology and Pathophysiology of Diuretic Action Copyright © 2013 Elsevier Inc. All rights reserved.
By D. Fisher Geometric Transformations. Reflection, Rotation, or Translation 1.
Business Transaction Management Software for Application Coordination 1 Business Processes and Coordination.
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Title Subtitle.
Making a Line Plot Collect data and put in chronological order
0 - 0.
1 1  1 =.
1  1 =.
ALGEBRAIC EXPRESSIONS
DIVIDING INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
MULTIPLYING MONOMIALS TIMES POLYNOMIALS (DISTRIBUTIVE PROPERTY)
ADDING INTEGERS 1. POS. + POS. = POS. 2. NEG. + NEG. = NEG. 3. POS. + NEG. OR NEG. + POS. SUBTRACT TAKE SIGN OF BIGGER ABSOLUTE VALUE.
MULTIPLICATION EQUATIONS 1. SOLVE FOR X 3. WHAT EVER YOU DO TO ONE SIDE YOU HAVE TO DO TO THE OTHER 2. DIVIDE BY THE NUMBER IN FRONT OF THE VARIABLE.
SUBTRACTING INTEGERS 1. CHANGE THE SUBTRACTION SIGN TO ADDITION
MULT. INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
Addition Facts
Year 6 mental test 5 second questions
Year 6 mental test 15 second questions Numbers and number system Numbers and the number system, Measures and Shape.
Gestational weight gain in a UK cohort: patterns, risk factors and associations with later mother and offspring health Debbie A Lawlor
Who Wants To Be A Millionaire?
ZMQS ZMQS
Leadership. Knowledge. Community. Antiplatelet Therapy for the Primary Prevention of Vascular Events Working Group: Alan D. Bell, MD, CCFP and James D.
Collections in the Medical Office
ABC Technology Project
Filling and Wrapping Review Sheet
2 |SharePoint Saturday New York City
O X Click on Number next to person for a question.
© S Haughton more than 3?
5.9 + = 10 a)3.6 b)4.1 c)5.3 Question 1: Good Answer!! Well Done!! = 10 Question 1:
Squares and Square Root WALK. Solve each problem REVIEW:
Energy & Green Urbanism Markku Lappalainen Aalto University.
ROCKET-AF Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial.
Lets play bingo!!. Calculate: MEAN Calculate: MEDIAN
Past Tense Probe. Past Tense Probe Past Tense Probe – Practice 1.
Chapter 5 Test Review Sections 5-1 through 5-4.
GG Consulting, LLC I-SUITE. Source: TEA SHARS Frequently asked questions 2.
Section 7.1 (Part 2) 7.1 HW Quiz: Friday 7.1, 7.2 Quiz: Next Week sometime 7.1, 7.2, 7.7 Test: Sept. 22 Make-up work needs to be made up by Monday afternoon!
1 First EMRAS II Technical Meeting IAEA Headquarters, Vienna, 19–23 January 2009.
2011 WINNISQUAM COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=1021.
Benjamin Banneker Charter Academy of Technology Making AYP Benjamin Banneker Charter Academy of Technology Making AYP.
2011 FRANKLIN COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=332.
Addition 1’s to 20.
25 seconds left…...
Test B, 100 Subtraction Facts
= 2 = 4 = 5 = 10 = 12. Estimating Non-Perfect Squares For Integers that are NOT perfect squares, you can estimate a square root = 2.83.
11 = This is the fact family. You say: 8+3=11 and 3+8=11
Analysis of engineering system by means of graph representation.
Week 1.
We will resume in: 25 Minutes.
Bottoms Up Factoring. Start with the X-box 3-9 Product Sum
1 Unit 1 Kinematics Chapter 1 Day
Internet of things Claus Thybo 11 maj 2010
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
ESOFAGO DI BARRETT TERAPIA MEDICA & ENDOSCOPICA Massimo Conio Sanremo Massimo Conio Sanremo.
Endoscopic Treatment of Barrett’s Esophagus and Early Esophageal Cancer CTOP Retreat 2014 Dartmouth-Hitchcock Medical Center.
Senior Lecturer in Gastroenterology Consultant Gastroenterologist
Radiofrequency Ablation for Barrett’s Esophagus with HGD Gregory G. Ginsberg, M.D. Professor of Medicine University of Pennsylvania School of Medicine.
Dr Bernard Stacey Southampton General Hospital.  Incidence of adenocarcinoma of the oesophagus is fastest rising cancer in Western world  Majority present.
Contribution by: Prof. dr. med. Stefan Seewald
Bristol Royal Infirmary M.Boal, D. Titcomb 2/2/17
Barrx™ Radiofrequency Ablation System
Presentation transcript:

HALO foredrag Endoskopi Sygeplejerskernes Årsmøde 2013

Hvordan går det med Barrets Patienter i Kongeriget Danmark

Study of patients with BE Patients Patients, entire Denmark Age 62,7 years (mean), 67% male Follow-up patient-years ( in all studies to date) 18 years ( ) Median follow-up 5,2 y Hvid-Jensen et al, NEJM 2011; 365:

Study of patients with BE Results BE patients 72 HGD 131 adenoc. 106 HGD 66 adenoc. 1st year >1 year Hvid-Jensen et al, NEJM 2011; 365:

EAC in known BE patients 197 out of a total of 2602 EAC 7.6 % Hvid-Jensen et al, NEJM 2011; 365:

Study of patients with BE Results BE patients 72 HGD 131 adenoc. 106 HGD 66 adenoc. 1st year >1 year Risk for adenocarcinoma Risk for HGD 1,2/1000 pyrs (95%CI:0,9-1,5) /0,12 % per year 1,9/1000 pyrs (95%CI:1,6-2,3) Risk for adenocarcinoma or HGD 2,6/1000 pyrs (95%CI:2,2-3,1) Hvid-Jensen et al, NEJM 2011; 365:

Study of patients with BE Are there High-risk subgroups ? Low Grade Dysplasi (LGD) 1st endoscopy (5%) : ”ever” LGD (8%): No LGD at 1st endoscopy (95%) 1,0/1000 pyrs (0,7-1,3) 5,1/1000 pyrs (3,0-8,6) 5,5/1000 pyrs (3,7-8,3) Hvid-Jensen et al, NEJM 2011; 365:

Barrx TM Flex Generator 20 Barrx TM RFA Catheters

Proximal Distal The following is a representation of the procedural steps used in prospective clinical trials for this device. This guide is not meant to replace physician judgment. Procedural steps may vary by patient according to patient tolerability, anatomy, motility, characteristics of the Barrett’s esophagus, and underlying health condition. QUICK VIEW OF PROCEDURAL ASPECTS 1.Introduce endoscope, measure TIM/TGF, insert guidewire  Flush with Mucomyst and suction out 2.Remove endoscope, leave GW in place  Calibrate Sizing balloon 3.Introduce sizing balloon over GW 4.Start sizing 12 cm proximal to TGF, every 1 cm 5.Remove sizing balloon, leave GW in place 6.Introduce HALO 360+ ablation catheter over GW 7.Introduce endoscope along-side ablation catheter 8.Position proximal electrode edge 1-2 cm proximal to TIM 9.Ablate each 3 cm segment until overlapping TGF 10.Remove endoscope, catheter, and GW together (with direct visualization) 11.Introduce endoscope and clean ablation zone 12.Inflate and clean ablation electrode (outside of body) 13.Re-Insert GW and remove endoscope, leave GW in place 14.Re-Introduce ablation catheter over GW 15.Repeat steps Remove both items, re-introduce scope and evacuate gastric contents, inspect ablation zone 22 TGF Quick Overview Circumferential Ablation

HALO 360

Courtesy of Charlie Lightdale, M.D., Columbia Presbyterian, New York

Focal RFA Shaheen NJ, et al. N Engl J Med 2009

Complications Pain Dysphagia Bleeding Fever Vomiting Technical: Generel few problems – Captured HALO 90

Pain conclusions Bevare of the alcoholic patient Pain is common, also after HALO 90 Be carefull with Barrettsegment longer 5-6 cm Analgesic treatment? Kodeinmixture Weak morfin - Tramadol

Dysphagia

Bleeding and fever 3 patients with bleeding 10. – 14. day postop. All 3 with antikoagulantia (2 Warfarin 1 asa) 6 patients used antikoagulantia Comment: Use LMH 2-3 weeks after treatment before taking up Warfarin 4 patients with fever

GAVE Der er HALO godt men dyrt

Konklusion HALO er et godt værktøj til at abblation af fladeformet celleforandringer i specielt oesophagus. Giver nye behandlingsmuligheder af Barret’s Oesophagus. Specielt for de patienter med svære celleforandringer Det er forholdsvist nemt at bruge, men kræver dog en vis læringskurve Bagsiden at det er dyrt, og ikke uden komplikationer